NANOSPHERE INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-12-30: Form 8-K; Period of report 2011-12-28; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2011-11-02: Form 8-K; Period of report 2011-11-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2011-10-19: Form 8-K/A; Period of report 2011-06-01; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2011-08-09: Form 8-K; Period of report 2011-08-09; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2011-12-30 | 8-K | 2011-12-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On December 28, 2011 (the “Effective Date”), Nanosphere, Inc. (the “Company”) entered into a Second Amended and Restated Employment Agreement (the “Agreement”) with Mr. William P. Moffitt, the President and Chief Executive Officer of the Company. | d276219d8k.htm |
| 2011-11-02 | 8-K | 2011-11-02 | 2.02 Results of Operations and Financial Condition | 2.02 On November 2, 2011, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its third quarter ended September 30, 2011. | c24065e8vk.htm |
| 2011-10-19 | 8-K/A | 2011-06-01 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 (d) At the 2011 Annual Meeting, the Company’s stockholders voted, on a nonbinding advisory basis, on the frequency of future stockholder votes on the compensation of the Company’s Named Executive Officers every one, two or three years. | c23412e8vkza.htm |
| 2011-08-09 | 8-K | 2011-08-09 | 2.02 Results of Operations and Financial Condition | 2.02 On August 9, 2011, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its second quarter ended June 30, 2011. | c21168e8vk.htm |
| 2011-06-21 | 8-K | 2011-06-21 | 8.01 Other Events | 8.01 On June 9, 2011, the Company received a “not approvable” letter (“Letter”) from the staff of the Office of In Vitro Diagnostic Device Evaluation and Safety (“OIVD”) in the Center for Devices and Radiological Health (“CDRH”) at the U.S. Food and Drug Administration (“FDA”) with respect to its Pre-Market Approval (“PMA”) submission on the Company’s 2C19 (“Plavix Metabolism”) test. | c19017e8vk.htm |
| 2011-06-03 | 8-K | 2011-06-01 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 (a) Nanosphere, Inc. (the “Company”) held its annual meeting of shareholders on June 1, 2011 (the “Annual Meeting”). | c18406e8vk.htm |
| 2011-05-13 | 8-K | 2011-05-13 | 1.01 Entry into a Material Definitive Agreement | 1.01 On May 13, 2011, Nanosphere, Inc. (the “Company”) completed an underwritten public offering (the “Offering”) of 15,686,000 shares of its common stock, par value $0.01 per share (the “Shares”). | c17293e8vk.htm |
| 2011-05-10 | 8-K | 2011-05-10 | 7.01 Regulation FD Disclosure | 7.01 On May 10, 2011, Nanosphere, Inc. (the “Company”) (Nasdaq: NSPH) announced that it has priced its previously announced underwritten public offering of 13,640,000 shares of its common stock at a public offering price of $2.20 per share. | c16941e8vk.htm |
| 2011-05-09 | 8-K | 2011-05-09 | 7.01 Regulation FD Disclosure | 7.01 On May 9, 2011, Nanosphere, Inc. (the “Company”) (Nasdaq: NSPH) announced that it has commenced a public offering of shares of common stock. | c16637e8vk.htm |
| 2011-04-27 | 8-K | 2011-04-27 | 2.02 Results of Operations and Financial Condition | 2.02 On April 27, 2011, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its first quarter ended March 31, 2011. | c16014e8vk.htm |
| 2011-03-28 | 8-K | 2011-03-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) On March 22, 2011, James Nahirny, a member of the board of directors of Nanosphere, Inc. (the “Company”), notified the Company that he will not stand for re-election as a director at the annual meeting of stockholders on June 1, 2011. | c14753e8vk.htm |
| 2011-02-16 | 8-K | 2011-02-16 | 2.02 Results of Operations and Financial Condition | 2.02 On February 16, 2011, Nanosphere, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and fiscal year ended December 31, 2010. | c12729e8vk.htm |